Identification ofChlamydia pneumoniaeand NLRP3 inflammasome activation in Alzheimer’s disease retina

Chlamydia pneumoniae(Cp), an obligate intracellular bacterium, has been implicated in Alzheimer’s disease (AD), yet its role in retinal pathology remains unexplored. We analyzed postmortem tissues from 95 human donors and found 2.9-4.1-fold increases in Cp inclusions in AD retinas and brains, with no significant elevation in mild cognitive impairment (MCI). Proteomics revealed dysregulation of retinal and brain bacterial infection-related proteins and NLRP3 inflammasome pathways. NLRP3 expression was markedly elevated in MCI and AD retinas, and its activation was evident by increased N-terminal gasdermin D (NGSDMD) and mature interleukin-1β. Retinal Cp strongly correlated with Aβ₄₂and NLRP3 inflammasome components, which tightly linked to cleaved caspase-3-apoptotic and NGSDMD-pyroptotic cell death. Although retinal microgliosis was elevated in AD, Cp-associated microglia were reduced by 62%, suggesting impaired Cp phagocytosis. Higher retinal Cp burden correlated with APOEε4, Braak stage, and cognitive deficit. Machine learning identified retinal Cp or NLRP3 combined with Aβ₄₂as strong predictors of AD diagnosis, staging, and cognitive impairment. Our findings suggest that Cp infection contributes to AD dementia but not initiating pathology, whereas early NLRP3 activation may promote disease development, warranting studies on Cp’s role in AD pathogenesis and early antibiotic or inflammasome-targeted therapies.